Back to Authors

Weng, Jessica

0000-0002-8171-2223

Mayo Clinic

Mayo Clinic Medical Scientist Training Program, Mayo Clinic, Rochester, Minnesota, United States.

Citations 9

Effects of Common Therapies for Threatened Preterm Labor on the Placental Inflammatory Response
Weng, Jessica , Cortina, Francisco , Ling, Suyun , Girard, Sylvie , Sylvie, Girard , Weng, Jessica , Ling, Suyun

American Journal of Reproductive Immunology | August 31, 2026 | Volume: 96 | Issue: 3 | Pages: No page available

10.1111/aji.70316 Get It

ABSTRACT Problem Patients with threatened preterm labor (PTL) are treated with antibiotics, corticosteroids, and magnesium sulfate to mitigate infection, promote fetal lung maturation, provide fetal neuroprotection and overall minimize the impact of prematurity on the neonate. However, the effect of these drugs on the placental inflammatory profile is unknown even though these are given systemically and reach the placenta. We evaluated their action in an ex vivo model of placental inflammation. Method of Study Placental explants from uncomplicated pregnancies were exposed to lipopolysaccharide (LPS) ± azithromycin, betamethasone, and/or magnesium sulfate. Production (lysate) and secretion (supernatant) of pro‐ and anti‐inflammatory cytokines were assessed by ELISA. Results Both pro‐ and anti‐inflammatory cytokines were increased by LPS versus untreated. Azithromycin, or magnesium sulfate did not alter the inflammatory profile by themselves nor when added at the same time or 24 h after LPS. Betamethasone decreased both pro‐ and anti‐inflammatory cytokines only when administered at the same time as LPS, without any effects if delayed. Conclusions Therapeutic interventions classically used for preterm labor (PTL) do not impact the placental inflammatory profile by themselves or in the context of an ex vivo placental explants model of LPS‐induced inflammation, except for betamethasone when administered concurrently with LPS.
Factors affecting trainees’ preferred timing of clinical clerkships during MD-PhD training
Weng, Jessica , Cornelius, Katherine , Hurley, Lisa M., Hu, Leland , Ensign, Shannon P. Fortin , Torgerson, Rochelle R. , Maleszewski, Joseph J. , Horazdovsky, Bruce , Weroha, Saravut J., Trentadue, Taylor P , Weng, Jessica , Bouchal, Samantha M , Cornelius, Katherine E , Hu, Leland S , Ensign, Shannon P. Fortin , Maleszewski, Joseph J , Horazdovsky, Bruce F , Kaufmann, Scott H , Weroha, S John , Schimmenti, Lisa A , Trentadue, Taylor P. , Bouchal, Samantha M. , Kaufmann, Scott H. , Schimmenti, Lisa A.

No container title available | May 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.05.10.26352845 Get It

Abstract M.D.-Ph.D. programs in the United States have traditionally followed a “2- n -2” curricular model, with the graduate phase occurring between the pre-clerkship and clerkship portions of medical training. While well established, this format can limit trainee autonomy in shaping their physician-scientist training trajectories. In response, some programs have introduced a “3- n -1” model, allowing students to complete clerkships before beginning Ph.D. training. Our institution implemented multiple flexible curricula in 2017. Understanding why trainees choose one pathway is important as programs consider implementing more adaptable training structures. To investigate these factors, we surveyed M.D.-Ph.D. students at our institution, which offers multiple flexible curricular alternatives, about contributions to their curricular decisions. Responses supported that trainees weigh considerations across medical education, scientific development, and integrated physician-scientist training domains. Although the traditional pathway was a popular option, most students pursued one of the flexible pathways. Our findings suggest that introducing flexibility in the timing of undergraduate medical education and graduate training can support diverse educational, logistical, and personal priorities while maintaining the rigor of physician-scientist training. Offering multiple pathways empowers trainees to design trajectories that best fit their needs. Continued longitudinal studies are needed to assess the long-term impacts of flexible curricula on physician-scientist career outcomes.
Abandoning Reproductive Science Betrays Us All
Weng, Jessica , Wayland, Jennifer L. , Mysorekar, Indira U. , Bonney, Elizabeth A. , Mysorekar, Indira U , Weng, Jessica

American Journal of Reproductive Immunology | December 20, 2025 | Volume: 94 | Issue: 6 | Pages: No page available

10.1111/aji.70199 Get It

Feasibility and Acceptability of Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer
Weng, Jessica , Wild, Ellen, Rhee, Laura, Piderman, Katherine M. , Santiago, Abraham Labrada, Rinker, Caila J., Felt, Melissa, Ingram, Cory , Pachman, Deirdre R. , Weng, Jessica , Chesak, Sherry S. , Santiago, Abraham Labrada, Rinker, Caila, Fischer, Karen M.

American Journal of Hospice and Palliative Medicine® | August 8, 2025 | Volume: 43 | Issue: 9 | Pages: 940-947

10.1177/10499091251361467 Get It

Background Patients with advanced cancer experience a substantial amount of existential and emotional distress. Dignity therapy (DT) is a brief, individualized psychotherapy that aims to relieve existential distress and improve the experiences of individuals impacted by serious illness. Aim To evaluate the feasibility and acceptability of virtual DT (vDT) among patients with advanced cancer. Methods This pilot study recruited adult patients with advanced cancer and an expected prognosis >6 months. The vDT intervention consisted of 2 sessions of guided interviews focused on life review, discussion, and development of a generativity document (GD). Feasibility and acceptability were assessed quantitatively and with semi-structured interviews. Effectiveness measures (distress, dignity impact scale, quality of life [QOL]) were administered pre/post intervention. Results Thirty-one patients referred from a palliative care clinic were eligible. Twenty-one consented and 15 received a final GD. Patients who completed final assessments (N = 9) reported satisfaction with their experience and would recommend the therapy to others. Patients found the virtual component of the intervention acceptable, and the majority noted an improvement in their dignity. Qualitative analysis revealed themes of study team effectiveness, perspectives on intervention processes, benefits to self, and benefits to loved ones. Conclusion Participation in vDT intervention was feasible and acceptable for patients. Patients appreciated the connection with the interviewer, the process, and the benefit of having a document to share with loved ones. Preliminary effectiveness data suggest vDT improves sense of dignity.
2024 Physician-Scientist Trainee Diversity Summit conference proceedings
Weng, Jessica , Tang, Cynthia Y. , Enriquez, Kyle T. , Guin, R.N., Christophers, Briana , Albrecht, Yentli E. Soto , Amusin, Daniel B, Rupert, Deborah D., Byas, Paige Cooper, Weng, Jessica , Guin, Rohini N. , Amusin, Daniel Boris

Journal of Clinical and Translational Science | February 11, 2025 | Volume: 9 | Issue: 1 | Pages: No page available

10.1017/cts.2025.24 Get It

Abstract The Physician-Scientist Trainee Diversity Summit, hosted by the American Physician Scientists Association and the Burroughs Wellcome Fund, was conceived in 2019 with the mission of developing strategic plans to diversify the physician-scientist community using human-centered design thinking. In June 2024, the second iteration of this conference was held in Raleigh, North Carolina, and brought together a network of scientific and medical organizations to discuss issues of justice, equity, diversity, and inclusion facing physician-scientist trainees. This article summarizes the progress made from the first meeting, the proceedings of the 2024 Summit, and a thematic analysis of the recent meeting, offering tangible solutions to the physician-scientist community for supporting diversity and accessibility.
Empowering Reproductive Healthcare: Reflections and Calls to Action From the 2024 American Society of Reproductive Immunology (ASRI) Meeting Policy Advocacy Session
Powell, Anna , Weng, Jessica , Jones, Brittany R., Johnson, Ann, Bonney, Elizabeth A. , Mysorekar, Indira U. , Mysorekar, Indira U , Weng, Jessica , Hesse, Lauren, Johnson, Ann

American Journal of Reproductive Immunology | October 16, 2024 | Volume: 92 | Issue: 4 | Pages: No page available

10.1111/aji.13943 Get It

Innate and Adaptive Immune Systems in Physiological and Pathological Pregnancy
Weng, Jessica , Couture, Camille , Weng, Jessica , Girard, Sylvie

Biology | March 3, 2023 | Volume: 12 | Issue: 3 | Pages: 402

10.3390/biology12030402 Get It

The dynamic immunological changes occurring throughout pregnancy are well-orchestrated and important for the success of the pregnancy. One of the key immune adaptations is the maternal immune tolerance towards the semi-allogeneic fetus. In this review, we provide a comprehensive overview of what is known about the innate and adaptive immunological changes in pregnancy and the role(s) of specific immune cells during physiological and pathological pregnancy. Alongside this, we provided details of remaining questions and challenges, as well as future perspectives for this growing field of research. Understanding the immunological changes that occur can inform potential strategies on treatments for the optimal health of the neonate and pregnant individual both during and after pregnancy.
Call to Action: Disaggregating the Asian American Medical Student Experience
Weng, Jessica , Zhu, Agnes , Chen, Christina Ying Ying, Weng, Jessica

Academic Medicine | November 30, 2022 | Volume: 97 | Issue: 12 | Pages: 1728-1728

10.1097/acm.0000000000004965 Get It

Dignity Conserving Therapy: An Intervention for Addressing Psychosocial and Existential Distress in Patients with Serious Illness
Weng, Jessica , Pachman, Deirdre R. , Wild, Ellen, Ingram, Cory , Ingram, Cory J, Weng, Jessica

Palliative Medicine Reports | September 16, 2022 | Volume: 3 | Issue: 1 | Pages: No page available

10.1089/pmr.2022.0016 Get It

Patients with serious illnesses may experience existential and psychosocial distress contributing to their pain and suffering. Addressing existential distress is challenging and may require a multidisciplinary approach. Often, providers feel uncomfortable or ill equipped to care for patients suffering from this distress. In the sample case, the patient has a life-limiting disease and is concerned about his family forgetting him, experiencing loss of dignity and narrative foreclosure. Loss of dignity is sensing hopelessness and worthlessness and a loss of self-determination. Narrative foreclosure is the premature conviction that one's life story has effectively ended. Beneficial interventions include meaning-centered psychotherapy and dignity therapy (DT). Both have an underlying theme of attempting to reverse the narrative foreclosure for patients with serious illnesses and maintain a sense of meaning in life. In addition, patients can be referred to palliative care to enhance coping and decrease depressive symptoms. Dr. Harvey Chochinov has outlined a framework that clinicians can use to care for their patients in a compassionate manner to specifically combat meaninglessness. In DT, a generativity document is created for the patient and their loved ones as part of the treatment along with the opportunity to answer the dignity conserving question. Success of this route of intervention includes greater will to live, reductions in stress, and benefits perceived by family. This article aims to give a framework to treat patients with serious illnesses experiencing psychosocial and/or existential distress.